英文名稱 |
中文名稱 |
CAS號 |
操作 |
Mirtazapine iMpurity |
米氮平雜質(zhì) |
1188331-80-7 |
詳細
|
Montelukast iMpurity |
孟魯司特雜質(zhì) |
|
詳細
|
Mycophenolate IMpurity |
霉酚酸雜質(zhì) |
|
詳細
|
Alfuzosin impurity |
阿夫唑嗪雜質(zhì) |
|
詳細
|
Ampicillin impurity |
氨芐青霉素雜質(zhì) |
|
詳細
|
Oxaliplatin impurity |
奧沙利鉑雜質(zhì) |
|
詳細
|
Acebutolol EP Impurity D |
醋丁洛爾雜質(zhì) |
|
詳細
|
Diltiazem impurity |
地爾硫卓雜質(zhì) |
115992-91-1 |
詳細
|
DONEPEZIL IMP |
多奈哌齊雜質(zhì) |
923571-16-8 |
詳細
|
Empagliflozin Impurity |
恩格列凈雜質(zhì) |
2253771-11-6 |
詳細
|
Entacapone |
恩他卡朋雜質(zhì) |
|
詳細
|
Glimepiride impurity |
格列美脲雜質(zhì) |
|
詳細
|
Ciprofloxacin impurity |
環(huán)丙沙星雜質(zhì) |
|
詳細
|
Methotrexate impurity |
甲氨蝶呤雜質(zhì) |
|
詳細
|
Ramipril impurity |
雷米普利雜質(zhì) |
|
詳細
|
2',3'-Didehydro Lovastatin |
洛伐他汀雜質(zhì) |
|
詳細
|
Meloxicam impurity |
美洛昔康雜質(zhì) |
|
詳細
|
Nizatidine impurity |
尼扎替丁雜質(zhì) |
|
詳細
|
Paliperidone impurity |
帕潘立酮雜質(zhì) |
|
詳細
|
Dioxin impurity |
潘生丁雜質(zhì) |
|
詳細
|
Perindopril Impurity |
培哚普利雜質(zhì) |
|
詳細
|
Group Doppler impurity |
群多普利雜質(zhì) |
|
詳細
|
Sumatriptan |
舒馬曲坦雜質(zhì) |
|
詳細
|
Diacerein impurity |
雙醋瑞因雜質(zhì) |
|
詳細
|
Diclofenac |
雙氯芬酸雜質(zhì) |
|
詳細
|
(4R,5S)-4,5-Dichloro-4,5-dimethyl-1,3-dioxolan-2-one |
奧美沙坦雜質(zhì) |
116857-04-6 |
詳細
|
rac-3-Des[2-(dimethylamino)ethyl]-Zolmitriptan 3-Acetic Acid-d3 |
佐米曲普坦雜質(zhì) |
1432902-38-9 |
詳細
|
Zolpidem |
唑吡坦雜質(zhì) |
365213-58-7 |
詳細
|
Nebivolol O-Beta-D-Glucuronide |
奈必洛爾雜質(zhì) |
|
詳細
|
nifedipine iMpurity |
硝苯地平雜質(zhì) |
|
詳細
|
NiMesulide EP IMpurity |
尼美舒利雜質(zhì) |
38880-53-4 |
詳細
|
O-Isobutyryl (R)-Fesoterodine |
弗斯特羅定雜質(zhì) |
1208313-13-6 |
詳細
|
OMEPRAZOLE IMPURITY DOMEPRAZOLE SULPHONE EP STANDARD |
奧美拉唑雜質(zhì) |
|
詳細
|
OMEPRAZOLE IMPURITY DOMEPRAZOLE SULPHONE EP STANDARD |
蘭索拉唑雜質(zhì) |
1083100-27-9 |
詳細
|
Ondansetron IMpurity |
恩丹西酮雜質(zhì) |
|
詳細
|
OseltaMivir iMpurity E |
奧司他韋雜質(zhì) |
903907-74-4 |
詳細
|
(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan |
(3S)-3-[4-[(2-氯-5-碘苯基)甲基]苯氧基]四氫呋喃(依帕列凈中間體);依帕列凈雜質(zhì) C;(S)-3-(4-(2-氯-5-碘芐基)-苯氧基)-四氫呋喃 |
915095-94-2 |
詳細
|
(E)-3α-hydroxy-6-ethylidene-7-keto-5β-cholan-24-oic acid |
奧貝膽酸中間體-3;3A羥基-7氧代-膽烷酸甲酯;奧貝膽酸中間體;奧貝膽酸中間體 OB-3 |
1516887-33-4 |
詳細
|
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene |
坎格列凈中間體;坎格列凈的中間體;2-(2-甲基-5-溴芐基)-5-(4-氟苯)噻吩(坎格列凈中間體);卡格列凈 中間體 KG-1.1 |
898566-17-1 |
詳細
|
2-(5-BroMo-2-Methylbenzyl)-5-(4-fluorophenyl)thiophene |
2-(2-甲基-5-溴芐基)-5-(4-氟苯)噻吩;2-[(5-溴-2-甲基苯基)甲基]-5-(4-氟苯基)噻吩;坎格列凈中間體1 |
1030825-20-7 |
詳細
|
Canagliflozin |
卡格列凈(半水合物) |
928672-86-0 |
詳細
|
Canagliflozin |
卡格列凈(無水合物) |
842133-18-0 |
詳細
|
Carfilzomib |
卡非佐米 |
868540-17-4 |
詳細
|
EMpagliflozin |
(1S)-1,5-脫水-1-C-[4-氯-3-[[4-[[(3S)-四氫-3-呋喃基]氧基]苯基]甲基]苯基]-D-葡萄糖醇;艾帕列凈;依帕列凈;恩格列嗪;恩格列嗪 EMPAGLIFLOZIN;恩格列凈/依帕列凈;恩格列凈;艾帕列凈/依帕列凈雜質(zhì) |
864070-44-0 |
詳細
|
(2S)-2-Amino-4-methyl-1-((2R)-2-methyloxiranyl)-1-pentanone Trifluoroacetate |
卡非佐米側(cè)鏈中間體 |
247068-85-5 |
詳細
|
Paroxetine IMpurity |
帕羅西汀雜質(zhì) |
|
詳細
|
Pioglitazone BroMo IMpurity |
吡格列酮雜質(zhì) |
|
詳細
|
PiroxicaM IMpurity ( N-(2-Pyridinyl)oxaMic Acid ) |
吡羅昔康雜質(zhì) |
|
詳細
|
Pitavastatin IMpurity 4 (PP-4) |
匹伐他汀雜質(zhì) |
1422058-54-5 |
詳細
|
Pravastatin iMpurity (6a-OH-iso-coMpactin OH acid) |
普伐他汀雜質(zhì) |
|
詳細
|
Pregabalin IMpurity |
普瑞巴林雜質(zhì) |
159029-27-3 |
詳細
|
Quetiapine IMpurity [2-(2-Piperazin-1-yl)ethoxy)ethanol] |
喹硫平雜質(zhì) |
2206135-50-2 |
詳細
|
Quinapril IMpuriy |
喹那普利雜質(zhì) |
|
詳細
|
Rabeprazole iMpurity (Chloro interMediate |
雷貝拉唑 |
117976-89-3 |
詳細
|
Raloxifene EP IMpurity |
雷洛昔芬雜質(zhì) |
1700655-64-6 |
詳細
|
REPAGLINIDE RELATED COMPOUND C (25 MG) ((S)-2-ETHOXY-4-[2-[[2-PHENYL-1 -[2-(1 -PIPERIDINYL)PHE-NYL]ETHYL]AMINO]-2-OXOETHYL] BENZOIC ACID) |
瑞格列奈雜質(zhì) |
107362-12-9 |
詳細
|
Rivastigmine |
卡巴拉汀雜質(zhì) |
123441-03-2 |
詳細
|
Pantoprazole IMpurity (Mixture of IMpurity D and F) |
泮托拉唑雜質(zhì) |
|
詳細
|
Rosuvastatin IMpurity (5-Oxo Rosuvastatin tert-Butyl Ester) |
瑞舒伐他汀雜質(zhì) |
854898-53-6 |
詳細
|
SalbutaMol IMpurity C |
沙丁胺醇雜質(zhì) |
|
詳細
|
SalMeterol IMpurity |
沙美特羅雜質(zhì) |
144391-74-2 |
詳細
|
Sertraline IMpurity (SRTRC-3) |
舍曲林雜質(zhì) |
|
詳細
|
Sildenafil Aldehyde IMpurity |
西地那非雜質(zhì) |
845302-49-0 |
詳細
|
Sitagliptin iMpurity |
西他列汀雜質(zhì) |
1675201-14-5 |
詳細
|
Stugeron |
桂利嗪雜質(zhì) |
298-57-7 |
詳細
|
TaMsulosin EP IMpurity |
坦索羅辛雜質(zhì) |
1798904-07-0 |
詳細
|
TICARCILLIN IMPURITY |
替卡西林雜質(zhì) |
|
詳細
|
TOPOTECANACETATE |
拓撲替康雜質(zhì) |
123948-88-9 |
詳細
|
TranexaMic Acid iMpurity |
氨甲環(huán)酸雜質(zhì) |
|
詳細
|
Valaciclovir iMpurity |
伐昔洛韋雜質(zhì) |
|
詳細
|
COLURACETAM |
N-(2,3-二甲基-5,6,7,8-四氫呋喃并[2,3-B]喹啉-4-基)-2-(2-氧代吡咯烷-1-基)乙酰胺;考拉西坦 |
135463-81-9 |
詳細
|
Atorvastatin Calcium Impurity VI Degradation Product |
氧氟沙星光降解雜質(zhì) |
151377-74-1 |
詳細
|
LY2835219 |
LY2835219中間體二 |
1180132-17-5 |
詳細
|
LY2835219 |
LY2835219中間體三 |
1231930-37-2 |
詳細
|
LY2835219 |
LY2835219中間體四 |
1231930-33-8 |
詳細
|
Rucaparib |
瑞卡帕布(AG-014699) |
459868-92-9 |
詳細
|
Vortioxetine |
沃替西汀 |
508233-74-7 |
詳細
|
ABT-199 |
ABT-199 |
1257044-40-8 |
詳細
|
AP26113 |
AP26113 |
1197958-12-5 |
詳細
|
CO-1686 |
CO1686 |
1374640-70-6 |
詳細
|
CO-1686 |
CO-1686 中間體二 |
68621-88-5 |
詳細
|
CO-1686 |
CO-1686 中間體三 |
1021426-42-5 |
詳細
|
CO-1686 |
CO-1686 中間體一 |
1374507-23-9 |
詳細
|
Edoxaban |
依度沙班 |
1229194-11-9 |
詳細
|
LY2835219 |
阿貝西利 |
1231929-97-7 |
詳細
|
LY2835219 |
LY2835219 中間體一 |
1231930-42-9 |
詳細
|
Vortioxetine (Lu AA21004) HBr |
沃替西汀氫溴酸鹽 |
960203-27-4 |
詳細
|
WZ3146 |
WZ3146 |
1214265-56-1 |
詳細
|
WZ4002 |
WZ4002 |
1213269-23-8 |
詳細
|
WZ8040 |
WZ8040 |
1214265-57-2 |
詳細
|
Naltrexone hydrochloride impurity A |
鹽酸納曲酮雜質(zhì)A |
|
詳細
|
Naltrexone hydrochloride impurity B |
鹽酸納曲酮雜質(zhì)B |
|
詳細
|
Naltrexone hydrochloride impurity C |
鹽酸納曲酮雜質(zhì)c |
|
詳細
|
Methyl 2,3,4-trifluoro-5-nitrobenzoate |
2,3,4-三氟-5-硝基苯甲酸甲酯 |
918321-24-1 |
詳細
|
1,2,3-Trithiane-4-pentanoic Acid |
硫辛酸雜質(zhì)A |
1204245-29-3 |
詳細
|
(S)-Cinacalcet hydrochloride |
S-鹽酸西那卡塞 |
1217809-88-5 |
詳細
|
J |
替米沙坦雜質(zhì)J |
1026258-58-1 |
詳細
|
(S)-(+)-2-Chlorophenylglycine methyl ester |
S-鄰氯苯甘氨酸甲酯酒石酸鹽 |
141109-14-0 |
詳細
|
4-Amino-3-chlorophenol hydrochloride |
3-氯-4-氨基苯酚鹽酸鹽 |
52671-64-4 |
詳細
|
Entecavir Impurity |
恩替卡韋雜質(zhì) |
1333204-94-6 |
詳細
|